| Nov 20 |
Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)
|
| Nov 18 |
Gilead’s Livdelzi shows promise in PBC clinical trial
|
| Nov 15 |
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
|
| Nov 15 |
Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis
|
| Nov 14 |
Gilead, Vertex initiated as new big biotech buys at Citi
|
| Nov 14 |
Citi initiates coverage on 5 new biotech stocks
|
| Nov 14 |
Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet
|
| Nov 14 |
Gilead Sciences prices $3.5B senior notes
|
| Nov 14 |
Gilead Prices $3.5 Billion of Senior Unsecured Notes
|
| Nov 13 |
Gilead reports positive HIV PrEP data for lenacapavir
|
